Clinical Trial Update: Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042) [Phase 2]

View source ↗

Summary

This completed Phase 2 pharmacokinetic study evaluated caspofungin acetate in immunocompromised young children with febrile neutropenia to characterize drug exp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infections

Drugs mentioned

• Caspofungin Acetate (caspofungin acetate)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Fungal Infection | Phase 2 | Status: COMPLETED